or Try an Advanced Search...

    ETF Components for BBC - Virtus LifeSci Biotech Clinical Trials ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    NRIX C 2.54 1.12
    MORF C 1.76 1.09
    IRON C 6.75 1.02
    CELC B 0.74 0.97
    PHVS F 0.89 0.97
    RCKT F 1.26 0.94
    ARQT B 3.23 0.93
    NUVB D -1.68 0.92
    NUVL C -1.30 0.92
    LBPH B 3.81 0.92
    IMVT F -1.21 0.92
    PCVX B 0.26 0.91
    DYN C -1.62 0.91
    SLN D -0.50 0.91
    DNLI C -2.02 0.91
    ARWR C -0.59 0.91
    CLDX D -2.97 0.90
    CYTK D -0.80 0.90
    ANAB B 4.01 0.89
    MRUS C -0.26 0.89
    SMMT C -8.62 0.89
    RXRX F 2.65 0.89
    PRTA F -1.57 0.88
    XENE F -1.20 0.88
    RNA C -4.10 0.88
    ELVN C -0.69 0.88
    RVMD D -1.23 0.88
    JANX D -2.04 0.88
    PGEN C -1.34 0.88
    BEAM D 4.03 0.87
    ACLX B 2.76 0.87
    ABUS B 0.96 0.87
    BLTE C 0.55 0.87
    SAVA F -8.65 0.87
    VRDN F 0.74 0.87
    EWTX C -0.54 0.87
    KURA D -2.53 0.86
    ERAS C -6.03 0.86
    AKRO D -2.01 0.86
    CRNX D -2.94 0.86
    MLYS D 0.50 0.86
    OLMA D 2.50 0.85
    VERA D -0.11 0.85
    RGNX F 0.65 0.85
    SNDX D -2.81 0.85
    ALLO F -3.70 0.85
    IDYA F -1.28 0.84
    RCUS F -1.98 0.84
    REPL D -3.35 0.84
    VERV F 2.80 0.84
    SVRA D 0.70 0.84
    MGNX F 2.44 0.83
    VKTX D -2.08 0.83
    KROS F -1.49 0.83
    PTGX B -0.26 0.83
    NTLA F 3.61 0.83
    ARVN F -3.82 0.83
    COGT C 1.46 0.83
    IMTX C -1.66 0.83
    EDIT F 2.64 0.82
    XNCR F 1.92 0.82
    TERN C 2.08 0.82
    PLRX F -0.19 0.82
    LQDA D 1.10 0.82
    CNTA D -2.17 0.81
    ITOS D 2.35 0.81
    FDMT D 1.31 0.81
    CGON F -1.56 0.81
    HLVX D -1.26 0.80
    ALEC F 1.61 0.80
    CVAC F -6.59 0.80
    VIR F -1.02 0.80
    KYMR D -0.20 0.80
    CMPS D 5.20 0.79
    ORIC F 0.00 0.79
    RLAY F -3.09 0.78
    TYRA D 1.62 0.77
    SRRK F 1.83 0.77
    IGMS F 0.78 0.77
    APLT D 0.69 0.76
    ETNB F -1.58 0.76
    QURE F -2.49 0.76
    ARCT F 2.09 0.75
    ABCL F -2.17 0.74
    BCYC F -1.16 0.74
    STOK D -1.25 0.72
    LYEL F 0.00 0.71
    ALXO F -2.10 0.70
    ANNX D 5.04 0.69
    FULC F 0.90 0.69
    AUTL F 3.25 0.69
    CGEM D 2.88 0.68
    SANA F -2.43 0.68
    PRME F 1.14 0.67
    WVE D 1.92 0.66
    IMNM F 3.59 0.65
    LRMR D -1.04 0.65
    TSHA F -0.46 0.53
    CABA F 2.17 0.52
    ZNTL F -2.52 0.40
    AVTE F 4.32 0.05

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Biotechnology Medicine Cancer Clinical Medicine Life Sciences Biology Immunology Disease Immune System Solid Tumors Antibodies Treatment Of Cancer Molecular Biology Organ Systems Autoimmune Disease Genetics Monoclonal Antibodies Monoclonal Antibody Acute Myeloid Leukemia
    Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Care Facilities

    Recent News for Virtus LifeSci Biotech Clinical Trials ETF & its Holdings

    Date Stock Title
    Jul 3 CYTK Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
    Jul 3 VKTX S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
    Jul 3 CVAC GSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines
    Jul 3 CVAC Moderna (MRNA) Secures BARDA Funding for Bird Flu Vaccine
    Jul 3 CVAC Biggest stock movers today: Electric vehicle stocks, PARAA, CVAC, and more
    Jul 3 LBPH Top 3 Health Care Stocks That May Crash This Quarter
    Jul 3 ALXO Annovis (ANVS) Up as Its Lead Candidate Meets Goals in PD Study
    Jul 3 KURA Estimating The Intrinsic Value Of Kura Oncology, Inc. (NASDAQ:KURA)
    Jul 3 CVAC GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
    Jul 3 CVAC GSK to Buy COVID-19, Flu Vaccine Rights From CureVac for $1.56 Billion
    Jul 3 CVAC CureVac cuts jobs, licenses out vaccines to GSK
    Jul 3 RNA Avidity’s FSHD drug del-brax shows promise in Phase I/II trial
    Jul 3 CVAC GSK to Buy CureVac’s Covid-19, Flu Vaccine Rights for Up to $1.56 Billion
    Jul 3 CVAC GSK and CureVac restructure mRNA vaccine development deal
    Jul 3 CVAC CureVac Enters Into New Licensing Agreement With GSK; to Implement 'Significant' Restructuring; Shares Rise Pre-Bell
    Jul 3 CVAC CureVac to cut 30% of workforce as GSK buys rights to make flu, covid shots
    Jul 3 CVAC GSK and CureVac to Restructure Collaboration into New Licensing Agreement
    Jul 3 CVAC CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities
    Jul 3 CVAC GSK buys COVID, influenza vaccines from retrenching CureVac
    Jul 3 NTLA Cathie Wood's Ark Invest Sells Tesla Shares Worth $14.5M Amid Rally Driven By Q2 Delivery Numbers, Picks Up Palantir Shares Again Today
    The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.
    Biotechnology Health Sciences Drug Discovery Pharmacology Clinical Research Clinical Trial
    Back to the Main BBC Page...